Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Shriver

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1986
The use of computed tomography in the evaluation of mediastinal massesG M Graeber, C D Shriver, R A Albus, et al.
Annals of Surgical Oncology|February 25, 1999
Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph nodeT J Miner, C D Shriver, P R Flicek, et al.
Oncogene|June 23, 2015
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanismC R Goodman, T Sato, A R Peck, et al.
Oncogene|May 28, 2013
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expressionT Sato, T H Tran, A R Peck, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1986
The use of computed tomography in the evaluation of mediastinal massesG M Graeber, C D Shriver, R A Albus, et al.
Annals of Surgical Oncology|February 25, 1999
Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph nodeT J Miner, C D Shriver, P R Flicek, et al.
Oncogene|June 23, 2015
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanismC R Goodman, T Sato, A R Peck, et al.
Oncogene|May 28, 2013
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expressionT Sato, T H Tran, A R Peck, et al.
Pageof 4